1. Home
  2. COEP vs GORV Comparison

COEP vs GORV Comparison

Compare COEP & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • GORV
  • Stock Information
  • Founded
  • COEP 2017
  • GORV 1976
  • Country
  • COEP United States
  • GORV United States
  • Employees
  • COEP N/A
  • GORV N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • GORV Retail-Auto Dealers and Gas Stations
  • Sector
  • COEP Health Care
  • GORV Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • GORV Nasdaq
  • Market Cap
  • COEP 27.4M
  • GORV 25.3M
  • IPO Year
  • COEP N/A
  • GORV 2015
  • Fundamental
  • Price
  • COEP $9.42
  • GORV $0.24
  • Analyst Decision
  • COEP
  • GORV Hold
  • Analyst Count
  • COEP 0
  • GORV 2
  • Target Price
  • COEP N/A
  • GORV $2.00
  • AVG Volume (30 Days)
  • COEP 38.8K
  • GORV 2.3M
  • Earning Date
  • COEP 08-15-2025
  • GORV 08-15-2025
  • Dividend Yield
  • COEP N/A
  • GORV N/A
  • EPS Growth
  • COEP N/A
  • GORV N/A
  • EPS
  • COEP N/A
  • GORV N/A
  • Revenue
  • COEP $62,874.00
  • GORV $767,257,000.00
  • Revenue This Year
  • COEP N/A
  • GORV $15.65
  • Revenue Next Year
  • COEP N/A
  • GORV $20.54
  • P/E Ratio
  • COEP N/A
  • GORV N/A
  • Revenue Growth
  • COEP N/A
  • GORV N/A
  • 52 Week Low
  • COEP $2.31
  • GORV $0.13
  • 52 Week High
  • COEP $13.70
  • GORV $3.56
  • Technical
  • Relative Strength Index (RSI)
  • COEP 62.66
  • GORV 48.60
  • Support Level
  • COEP $7.25
  • GORV $0.22
  • Resistance Level
  • COEP $9.90
  • GORV $0.26
  • Average True Range (ATR)
  • COEP 0.68
  • GORV 0.02
  • MACD
  • COEP 0.22
  • GORV 0.00
  • Stochastic Oscillator
  • COEP 87.10
  • GORV 51.29

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About GORV Lazydays Holdings Inc.

Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.

Share on Social Networks: